… an overview of cataract epidemiology, cataract risk factors and cataract-related economic …
factors of PSCs are high myopia, diabetes and exposure to therapeutic doses of steroids and …

… longer term use of high-dose inhaled steroids, Boulet et al 15 … negligible attributable risk for
cataracts associated with ICSs. … to 6 years of treatment with inhaled BUD at an average dose …

… Effect of inhaled corticosteroids on the risk of cataract formation in patients with steroid-…
using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995; 8: 590–592. 12. …

… cataracts, 10.8 million and 35.1 million individuals were respectively blind and visually impaired.
In 2010, cataracts … knowledge about the risk of chronic use of steroids causing cataract. …

… cataract formation are risks associated with systemic steroids… patients taking nasal or inhaled
steroids and 38,325 controls. … evidence linking nasal steroids and cataracts or glaucoma. …

… is relatively safe, long-term use is not recommended due to the risk of major adverse effects.
… for oral steroids like prednisone may reduce after the introduction of inhaled steroids. Unlike …

… with a greater risk for cataracts. One study … prednisone would be 8.5:1. In this way, we
can extrapolate that approximately 1000 mcg of fluticasone would equal 8.5 mg of prednisone …

… risks associated with ICS tend to be minimal at short-term low-dose treatment, whereas
high-dose ICS treatment requires more attention, with possible susceptibility to both cataract …

… inhaled steroids at an increased risk of developing ocular malfunctions and if so, how large
is the risk … associated with increased occurrence of cataracts, glaucoma, xerophthalmia and …

… risks of glucocorticosteroids in the treatment of allergic inflammation. Many factors influence
the balance of benefit and risk in … that may influence the benefit/risk ratio in an individual and …